SART1

Revision as of 14:32, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Squamous cell carcinoma antigen recognized by T cells
Identifiers
Symbols SART1 ; Ara1; HOMS1; MGC2038; SART1259; Snu66
External IDs Template:OMIM5 Template:MGI HomoloGene38015
RNA expression pattern
File:PBB GE SART1 200052 s at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Squamous cell carcinoma antigen recognized by T cells, also known as SART1, is a human gene.[1]

This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway.[1]

References

  1. 1.0 1.1 "Entrez Gene: SART1 squamous cell carcinoma antigen recognized by T cells".

Further reading

  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
  • Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Res. 6 (9): 791–806. PMID 8889548.
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.
  • Shichijo S, Nakao M, Imai Y; et al. (1998). "A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes". J. Exp. Med. 187 (3): 277–88. PMID 9449708.
  • Valenta R, Natter S, Seiberler S; et al. (1999). "Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients". J. Invest. Dermatol. 111 (6): 1178–83. doi:10.1046/j.1523-1747.1998.00413.x. PMID 9856836.
  • Kikuchi M, Nakao M, Inoue Y; et al. (1999). "Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes". Int. J. Cancer. 81 (3): 459–66. PMID 10209962.
  • Matsunaga K, Nakao M, Masuoka K; et al. (1999). "Cytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptide". Jpn. J. Cancer Res. 90 (9): 1007–15. PMID 10551332.
  • Ishida H, Komiya S, Inoue Y; et al. (2000). "Expression of the SART1 tumor-rejection antigen in human osteosarcomas". Int. J. Oncol. 17 (1): 29–32. PMID 10853014.
  • Shintaku I, Kawagoe N, Yutani S; et al. (2000). "Expression of the SART1 tumor rejection antigen in renal cell carcinoma". Urol. Res. 28 (3): 178–84. PMID 10929426.
  • Tanaka S, Tsuda N, Kawano K; et al. (2001). "Expression of tumor-rejection antigens in gynecologic cancers". Jpn. J. Cancer Res. 91 (11): 1177–84. PMID 11092984.
  • Sasatomi T, Yamana H, Shichijo S; et al. (2001). "Expression of the SART1 tumor-rejection antigens in colorectal cancers". Dis. Colon Rectum. 43 (12): 1754–8. PMID 11156463.
  • Makarova OV, Makarov EM, Lührmann R (2001). "The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes". EMBO J. 20 (10): 2553–63. doi:10.1093/emboj/20.10.2553. PMID 11350945.
  • Bolland DJ, Hewitt JE (2001). "Intron loss in the SART1 genes of Fugu rubripes and Tetraodon nigroviridis". Gene. 271 (1): 43–9. PMID 11410364.
  • Jurica MS, Licklider LJ, Gygi SR; et al. (2002). "Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis". RNA. 8 (4): 426–39. PMID 11991638.
  • Bell M, Schreiner S, Damianov A; et al. (2002). "p110, a novel human U6 snRNP protein and U4/U6 snRNP recycling factor". EMBO J. 21 (11): 2724–35. doi:10.1093/emboj/21.11.2724. PMID 12032085.
  • Wheatley AP, Bolland DJ, Hewitt JE; et al. (2003). "Identification of the autoantigen SART-1 as a candidate gene for the development of atopy". Hum. Mol. Genet. 11 (18): 2143–6. PMID 12189166.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Vertegaal AC, Ogg SC, Jaffray E; et al. (2004). "A proteomic study of SUMO-2 target proteins". J. Biol. Chem. 279 (32): 33791–8. doi:10.1074/jbc.M404201200. PMID 15175327.
  • Beausoleil SA, Jedrychowski M, Schwartz D; et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi:10.1073/pnas.0404720101. PMID 15302935.

Template:WikiDoc Sources